Oyster Point Pharma

YTD

ALL

Why Robinhood?

You can watch OYST and buy or sell other stocks, options, and ETFs commission-free!

About OYST

Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharma’s lead product candidate, OC-01, a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.

CEO

Jeffrey A. Nau, PhD

CEOJeffrey A. Nau, PhD

Employees

—

Employees—

Headquarters

Princeton, New Jersey

HeadquartersPrinceton, New Jersey

Founded

2015

Founded2015

Employees

—

Employees—

OYST Key Statistics

Market cap

299.85M

Market cap299.85M

Price-Earnings ratio

-1.68

Price-Earnings ratio-1.68

Dividend yield

—

Dividend yield—

Average volume

498.96K

Average volume498.96K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$16.61

52 Week high$16.61

52 Week low

$3.46

52 Week low$3.46